Conserved amino acids within the adenovirus 2 E3/19K protein differentially affect downregulation of MHC class I and MICA/B proteins

Journal of Immunology

Volumn 184, Issue 1, 2010, Pages 255-267

  Sester, Martina ^a,b   Koebernick, Katja ^a,f   Owen, Douglas ^a   Ao, Minghui ^a   Bromberg, Yana ^c   May, Ed ^a   Stock, Emily ^a   Andrews, Lawrence ^a   Groh, Veronika ^d   Spies, Thomas ^d   Steinle, Alexander ^e   Menz, Beatrice ^a,g   Burgert, Hans Gerhard ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b SAARLAND UNIVERSITY   (Germany)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g Birkhäuser Verlag GmbH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EARLY TRANSCRIPTION UNIT 3; HLA ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN;

ADENOVIRUS 2; AMINO ACID SUBSTITUTION; ARTICLE; CELL SURFACE; CHLAMYDOSPORE; DOWN REGULATION; FLOW CYTOMETRY; IMMUNOPRECIPITATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS MUTANT; ADENOVIRUS INFECTION; AMINO ACID SEQUENCE; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN SECONDARY STRUCTURE;

ADENOVIRIDAE INFECTIONS; ADENOVIRUS E3 PROTEINS; AMINO ACID SEQUENCE; CONSERVED SEQUENCE; DOWN-REGULATION; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPRECIPITATION; POLYMERASE CHAIN REACTION; PROTEIN STRUCTURE, SECONDARY; TRANSFECTION;

EID: 73949154451     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902343     Document Type: Article

References (75)

1. Wold, W. S. M., and M. S. Horwitz. 2007. Adenoviruses. In Fields Virology, 5th Ed. , Knipe, D. M., P. M. Howley, D. E. Griffin, and R. A. Lamb, eds. Lippincott Williams & Wilkins, Philadelphia, p. 2395-2436.
2. Berk, A. J. 2007. Adenoviridae: The viruses and their replication. In Fields Virology, 5th Ed. , Knipe, D. M., P. M. Howley, D. E. Griffin, and R. A. Lamb, eds. Lippincott Williams & Wilkins, Philadelphia, p. 2355-2394.
3. Fox, J. P., C. E. Hall, and M. K. Cooney. 1977. The Seattle Virus Watch. VII. Observations of adenovirus infections. Am. J. Epidemiol. 105: 362-386.
4. Garnett, C. T., G. Talekar, J. A. Mahr, W. Huang, Y. Zhang, D. A. Ornelles, and L. R. Gooding. 2009. Latent species C adenoviruses in human tonsil tissues. J. Virol. 83: 2417-2428.
5. Burgert, H.-G., Z. Ruzsics, S. Obermeier, A. Hilgendorf, M. Windheim, and A. Elsing. 2002. Subversion of host defense mechanisms by adenoviruses. Curr. Top. Microbiol. Immunol. 269: 273-318.
6. Russell, W. C. 2009. Adenoviruses: update on structure and function. J. Gen. Virol. 90: 1-20.
7. Windheim, M., A. Hilgendorf, and H.-G. Burgert. 2004. Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways. Curr. Top. Microbiol. Immunol. 273: 29-85.
8. Lichtenstein, D. L., K. Toth, K. Doronin, A. E. Tollefson, and W. S. Wold. 2004. Functions and mechanisms of action of the adenovirus E3 proteins. Int. Rev. Immunol. 23: 75-111.
9. McNees, A. L., and L. R. Gooding. 2002. Adenoviral inhibitors of apoptotic cell death. Virus Res. 88: 87-101.
10. Burgert, H.-G., and J. H. Blusch. 2000. Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 21: 13-25.
11. Bruder, J. T., T. Jie, D. L. McVey, and I. Kovesdi. 1997. Expression of gp19K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver. J. Virol. 71: 7623-7628. (Pubitemid 27391705)
12. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S.Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. U.S.A. 86: 3823-3827.
13. von Herrath, M. G., S. Efrat, M. B. Oldstone, and M. S. Horwitz. 1997. Expression of adenoviral E3 transgenes in b cells prevents autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 94: 9808-9813.
14. Burgert, H.-G. 1996. Subversion of the MHC class I antigen-presentation pathway by adenoviruses and herpes simplex viruses. Trends Microbiol. 4: 107-112.
15. McSharry, B. P., H.-G. Burgert, D. P. Owen, R. J. Stanton, V. Prod'homme, M. Sester, K. Koebernick, V. Groh, T. Spies, S. Cox, et al. 2008. Adenovirus E3/ 19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B. J. Virol. 82: 4585-4594.
16. Elsing, A., and H.-G. Burgert. 1998. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci. U.S.A. 95: 10072-10077.
17. Schneider-Brachert,W., V. Tchikov, O. Merkel, M. Jakob, C. Hallas, M.-L. Kruse, P. Groitl, A. Lehn, E. Hildt, J. Held-Feindt, et al. 2006. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J. Clin. Invest. 116: 2901-2913.
18. Fessler, S. P., F. Delgado-Lopez, and M. S. Horwitz. 2004. Mechanisms of E3 modulation of immune and inflammatory responses. Curr. Top. Microbiol. Immunol. 273: 113-135.
19. Burgert, H.-G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41: 987-997. (Pubitemid 15243402)
20. Andersson, M., A. McMichael, and P. A. Peterson. 1987. Reduced allorecognition of adenovirus-2 infected cells. J. Immunol. 138: 3960-3966. (Pubitemid 17078280)
21. Cox, J. H., J. R. Bennink, and J. W. Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174: 1629-1637.
22. Rawle, F. C., A. E. Tollefson, W. S. Wold, and L. R. Gooding. 1989. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K. J. Immunol. 143: 2031-2037.
23. Tanaka, Y., and S. S. Tevethia. 1988. Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb-and H-2Db-restricted SV40-specific CTL-mediated lysis. Virology 165: 357-366.
24. Burgert, H.-G., J. L. Maryanski, and S. Kvist. 1987. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. U.S.A. 84: 1356-1360.
25. Hansen, T. H., and M. Bouvier. 2009. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9: 503-513.
26. Lodoen, M. B., and L. L. Lanier. 2005. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3: 59-69.
27. Jonjić, S., M. Babić, B. Polić, and A. Krmpotić. 2008. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20: 30-38.
28. Tomasec, P., E. C. Wang, V. Groh, T. Spies, B. P. McSharry, R. J. Aicheler, R. J. Stanton, and G. W. Wilkinson. 2007. Adenovirus vector delivery stimulates natural killer cell recognition. J. Gen. Virol. 88: 1103-1108.
29. Andersson, M., S. Pääbo, T. Nilsson, and P. A. Peterson. 1985. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43: 215-222. (Pubitemid 16199707)
30. Sester, M., and H.-G. Burgert. 1994. Conserved cysteine residues within the E3/ 19K protein of adenovirus type 2 are essential for binding to major histocompatibility complex antigens. J. Virol. 68: 5423-5432. (Pubitemid 24258554)
31. Nilsson, T., M. Jackson, and P. A. Peterson. 1989. Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58: 707-718.
32. Jackson, M. R., T. Nilsson, and P. A. Peterson. 1990. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9: 3153-3162. (Pubitemid 20282527)
33. Jackson, M. R., T. Nilsson, and P. A. Peterson. 1993. Retrieval of transmembrane proteins to the endoplasmic reticulum. J. Cell Biol. 121: 317-333. (Pubitemid 23110876)
34. Gabathuler, R., and S. Kvist. 1990. The endoplasmic reticulum retention signal of the E3/19K protein of adenovirus type 2 consists of three separate amino acid segments at the carboxy terminus. J. Cell Biol. 111: 1803-1810. (Pubitemid 120027149)
35. Teasdale, R. D., and M. R. Jackson. 1996. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus. Annu. Rev. Cell Dev. Biol. 12: 27-54.
36. Bennett, E. M., J. R. Bennink, J. W. Yewdell, and F. M. Brodsky. 1999. Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. J. Immunol. 162: 5049-5052.
37. Sester, M., D. Feuerbach, R. Frank, T. Preckel, A. Gutermann, and H.-G. Burgert. 2000. The amyloid precursor-like protein 2 associates with the major histocompatibility complex class I molecule K(d). J. Biol. Chem. 275: 3645-3654.
38. Liu, H., W. F. Stafford, and M. Bouvier. 2005. The endoplasmic reticulum lumenal domain of the adenovirus type 2 E3-19K protein binds to peptide-filled and peptide-deficient HLA-Ap1101 molecules. J. Virol. 79: 13317-13325.
39. Morris, C. R., J. L. Petersen, S. E. Vargas, H. R. Turnquist, M. M. McIlhaney, S. D. Sanderson, J. T. Bruder, Y. Y. L. Yu, H.-G. Burgert, and J. C. Solheim. 2003. The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expression. J. Biol. Chem. 278: 12618-12623.
40. Burgert, H.-G., and S. Kvist. 1987. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J. 6: 2019-2026.
41. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152: 3862-3872.
42. Feuerbach, D., S. Etteldorf, C. Ebenau-Jehle, J. P. Abastado, D. Madden, and H.-G. Burgert. 1994. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K. J. Immunol. 153: 1626-1636.
43. Jefferies, W. A., and H.-G. Burgert. 1990. E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins. J. Exp. Med. 172: 1653-1664.
44. Liu, H., J. Fu, and M. Bouvier. 2007. Allele- and locus-specific recognition of class I MHC molecules by the immunomodulatory E3-19K protein from adenovirus. J. Immunol. 178: 4567-4575. (Pubitemid 46492409)
45. Flomenberg, P., E. Gutierrez, and K. T. Hogan. 1994. Identification of class I MHC regions which bind to the adenovirus E3-19k protein. Mol. Immunol. 31: 1277-1284.
46. Körner, H., and H. G. Burgert. 1994. Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J. Virol. 68: 1442-1448. (Pubitemid 24065707)
47. Cox, J. H., J. W. Yewdell, L. C. Eisenlohr, P. R. Johnson, and J. R. Bennink. 1990. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715-718. (Pubitemid 120031356)
48. Kvist, S., L. Östberg, H. Persson, L. Philipson, and P. A. Peterson. 1978. Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc. Natl. Acad. Sci. U.S.A. 75: 5674-5678.
49. Lévy, F., and S. Kvist. 1990. Co-expression of the human HLA-B27 class I antigen and the E3/19K protein of adenovirus-2 in insect cells using a baculovirus vector. Int. Immunol. 2: 995-1002.
50. Pääbo, S., B. M. Bhat, W. S. Wold, and P. A. Peterson. 1987. A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum. Cell 50: 311-317.
51. Pääbo, S., F. Weber, T. Nilsson, W. Schaffner, and P. A. Peterson. 1986. Structural and functional dissection of an MHC class I antigen-binding adenovirus glycoprotein. EMBO J. 5: 1921-1927.
52. Gabathuler, R., F. Lévy, and S. Kvist. 1990. Requirements for the association of adenovirus type 2 E3/19K wild-type and mutant proteins with HLA antigens. J. Virol. 64: 3679-3685. (Pubitemid 20227190)
53. Hermiston, T. W., R. A. Tripp, T. Sparer, L. R. Gooding, and W. S. Wold. 1993. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 67: 5289-5298.
54. Pääbo, S., T. Nilsson, and P. A. Peterson. 1986. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc. Natl. Acad. Sci. U.S.A. 83: 9665-9669.
55. Deryckere, F., and H.-G. Burgert. 1996. Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. J. Virol. 70: 2832-2841. (Pubitemid 26121895)
56. Flomenberg, P., J. Szmulewicz, E. Gutierrez, and H. Lupatkin. 1992. Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules. J. Virol. 66: 4778-4783.
57. Menz, B., M. Sester, K. Koebernick, R. Schmid, and H.-G. Burgert. 2008. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies. Mol. Immunol. 46: 16-26.
58. Bromberg, Y., G. Yachdav, and B. Rost. 2008. SNAP predicts effect of mutations on protein function. Bioinformatics 24: 2397-2398.
59. Bromberg, Y., and B. Rost. 2007. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 35: 3823-3835.
60. Körner, H., U. Fritzsche, and H.-G. Burgert. 1992. Tumor necrosis factor a stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc. Natl. Acad. Sci. U.S.A. 89: 11857-11861.
61. Wold, W. S. M., A. E. Tollefson, and T. W. Hermiston. 1995. E3 transcription unit of adenovirus. Curr. Top. Microbiol. Immunol. 199/I: 237-274.
62. Hilgendorf, A., J. Lindberg, Z. Ruzsics, S. Höning, A. Elsing, M. Löfqvist, H. Engelmann, and H.-G. Burgert. 2003. Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. J. Biol. Chem. 278: 51872-51884.
63. Parham, P., and F. M. Brodsky. 1981. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum. Immunol. 3: 277-299.
64. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. U.S.A. 96: 6879-6884.
65. Welte, S. A., C. Sinzger, S. Z. Lutz, H. Singh-Jasuja, K. L. Sampaio, U. Eknigk, H. G. Rammensee, and A. Steinle. 2003. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 33: 194-203.
66. Bromberg, Y., J. Overton, C. Vaisse, R. L. Leibel, and B. Rost. 2009. In silico mutagenesis: a case study of the melanocortin 4 receptor. FASEB J. 23: 3059-3069.
67. Røder, G., L. Geironson, I. Bressendorff, and K. Paulsson. 2008. Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex. J. Virol. 82: 8246-8252.
68. Severinsson, L., I. Martens, and P. A. Peterson. 1986. Differential association between two human MHC class I antigens and an adenoviral glycoprotein. J. Immunol. 137: 1003-1009.
69. Feuerbach, D., and H. G. Burgert. 1993. Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K. EMBO J. 12: 3153-3161.
70. Tuli, A., M. Sharma, M. M. McIlhaney, J. E. Talmadge, N. Naslavsky, S. Caplan, and J. C. Solheim. 2008. Amyloid precursor-like protein 2 increases the endocytosis, instability, and turnover of the H2-K(d) MHC class I molecule. J. Immunol. 181: 1978-1987.
71. Tuli, A., M. Sharma, X. Wang, L. C. Simone, H. L. Capek, S. Cate, W. H. Hildebrand, N. Naslavsky, S. Caplan, and J. C. Solheim. 2009. Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunol. Immunother. 58: 1419-1431.
72. Flomenberg, P. R., M. Chen, and M. S. Horwitz. 1988. Sequence and genetic organization of adenovirus type 35 early region 3. J. Virol. 62: 4431-4437.
73. Pinto, A. K., A. M. Jamieson, D. H. Raulet, and A. B. Hill. 2007. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. J. Virol. 81: 12564-12571.
74. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2: 255-260.
75. Routes, J. M., S. Ryan, K. Morris, R. Takaki, A. Cerwenka, and L. L. Lanier. 2005. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J. Exp. Med. 202: 1477-1482.